diabetes

Health tech Lizzy Lawrence

STAT Plus: Dexcom CEO on strategy for bringing continuous glucose monitoring to type 2 diabetes patients

Health Elaine Chen

Stop taking Ozempic before surgery, anesthesiologist group recommends

Biotech Andrew Joseph

STAT Plus: U.K. agency declines to recommend Eli Lilly’s Mounjaro for type 2 diabetes

Health Elaine Chen

STAT Plus: Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial

Health tech Katie Palmer

STAT Plus: Does DIY still have a place in diabetes care? 

Biotech Jason Mast

STAT Plus: Two type 1 diabetes patients now freed from insulin shots with cell therapy, Vertex reports

Health Elaine Chen

STAT Plus: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial

Health Elaine Chen

Diabetes will be ‘a defining disease of this century’ as global cases are set to surpass one billion by 2050

Biotech Elaine Chen

STAT Plus: Akero’s NASH drug combined with Ozempic cut liver fat in small study

Health Elaine Chen

STAT Plus: Insurance alone didn’t guarantee adherence to Ozempic, study finds

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Big pharma maps legal strategy against U.S. drug pricing reform; U.S. pharma layoffs continue to climb

Politics Sarah Owermohle

STAT Plus: Q&A: Sen. Sanders on insulin costs and his committee’s generic drug kerfuffle

The Obesity Revolution Elaine Chen and Allison DeAngelis

STAT Plus: Beyond Wegovy and Ozempic: Biotechs vie for piece of red-hot weight loss market with novel strategies

Politics Rachel Cohrs

STAT Plus: Senate still hasn’t made hard decisions on lowering insulin costs

Exclusive Rachel Cohrs, John Wilkerson, and Ed Silverman

STAT Plus: Sanders plans to haul in insulin executives to testify in Senate

Health Elaine Chen

New study gets beyond BMI in pregnancy to gauge child’s risk of obesity

Health Elaine Chen

STAT Plus: British Columbia to bar Americans from buying Ozempic over supply concerns

Health Elaine Chen

Study suggests diabetes screening should be guided by age, not weight

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Sanofi cuts price on a popular insulin by 78%; Califf criticizes insurers for doing too little on drug research

Pharmalot Ed Silverman

STAT Plus: Novo Nordisk to lower insulin prices by up to 75% amid growing pressure

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap

Pharmalot Ed Silverman

STAT Plus: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment

Politics John Wilkerson

STAT Plus: By cutting insulin prices, Eli Lilly avoids paying big Medicaid rebates

The Obesity Revolution Elaine Chen and Matthew Herper

STAT Plus: New weight loss drugs are changing the narrative on obesity, with a push from pharma

The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: The next CRISPR fight, cheaper insulin, & an FDA shuffle

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Eli Lilly cuts prices for some insulin products; congressional committee opens probe into PBMs

Pharmalot Matthew Herper and Ed Silverman

Eli Lilly cuts prices for some insulin products, but some are wary

Health Matthew Herper

One type of artificial sweetener may increase heart attack risk, preliminary study says

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden wants $35 insulin cap for all Americans; pharma loses a court case over importing drugs from Canada